New Drug Counterfeiting Bill Introduced in US Congress
The Counterfeit Drug Enforcement Act of 2014 was introduced on December 11, 2014, by Rep. Steve Israel of New York. This bill, similar to ones previously introduced by Rep. Israel, would allow federal officials to sentence anyone found guilty of "knowingly" causing a drug to be adulterated or misbranded for periods up to life in prison.
Previous attempts to pass a bill along these lines have failed as the original patchwork of state pedigree regulations made counterfeit detection and investigation very difficult. With the passage of the new Drug Supply Chain Security Act that went into effect on January 1, 2015, establishing a national track and trace law, there may be greater bipartisan support this time around.
In addition to the sentencing provisions, a manufacturer made aware that its drugs may have been adulterated or misbranded must communicate that information to the FDA within 48 hours.
The proposed law also provides for additional funding for the FDA to investigate and fight counterfeit medicines.
Other elements of the bill provide for greater investigation powers such as the authority to issue subpoenas related to drug counterfeiting investigations.